Application Nr Approved Date Route Status External Links
NDA205580 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Bendamustine Hydrochloride Injection Is An Alkylating Drug Indicated For Treatment Of Patients With: Chronic Lymphocytic Leukemia (Cll). Efficacy Relative To First Line Therapies Other Than Chlorambucil Has Not Been Established. ( 1.1 ) Indolent B-Cell Non-Hodgkin Lymphoma (Nhl) That Has Progressed During Or Within Six Months Of Treatment With Rituximab Or A Rituximab-Containing Regimen. ( 1.2 ) 1.1 Chronic Lymphocytic Leukemia (Cll) Bendamustine Hydrochloride Injection Is Indicated For The Treatment Of Patients With Chronic Lymphocytic Leukemia. Efficacy Relative To First Line Therapies Other Than Chlorambucil Has Not Been Established. 1.2 Non-Hodgkin Lymphoma (Nhl) Bendamustine Hydrochloride Injection Is Indicated For The Treatment Of Patients With Indolent B-Cell Non-Hodgkin Lymphoma That Has Progressed During Or Within Six Months Of Treatment With Rituximab Or A Rituximab-Containing Regimen.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Bendamustine Hydrochloride BENDAMUSTINE HYDROCHLORIDE ZINC4214955

Comments